Join
Live feed
·
INSIDERFilingvia Quantisnow
ResMed Inc. logo

Chairman and CEO Farrell Michael J. was granted 13,551 units of ResMed Common Stock and covered exercise/tax liability with 7,297 units of ResMed Common Stock, increasing direct ownership by 1% to 466,223 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RMD (ResMed Inc.) and more on Quantisnow.